ZIMLAB · Health Care · 2026-08-07

ZIM Laboratories Ltd

4.9WatchEven +1.3Stage 2 · wk 13In scan: Pullback Hunter · Prop ScanMARKET: BULL TOPPING · 2026-08-07
₹112
-2.75% today
₹600 Cr · Small cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Visit company website →
P/E (TTM)
85.8
Forward —
Earnings Growth (YoY)
+20.8%
Revenue -3.3%
ROE
+2.1%
Profit margin +1.6%
vs 52W High
-12.4%
₹60.3 lo₹127.9 hi
12.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 13
1w13w26w
Week 13 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
31.1%
200 DMA: ₹85.4 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
1.04x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -3.0% vs MA50 +6.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
This stock ranks #57 of 79 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Ranks #38 of 53 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S? 17w
S3 16w
S4 19w
S4 19w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 17w → S2 5w → S3 16w → S4 13w → S1 10w → S4 3w → S1 2w → S2 6w → S3 6w → S4 2w → S3 2w → S2 4w → S4 19w → S1 6w → S2 5w → S3 2w → S4 19w → S1 7w → S4 7w → S1 2w → S2 12w current
Total tracked: 167 weeks across 21 stage runs.
1M
-3.4%
3M
+8.6%
6M
+50.2%
YTD
+63.5%
1Y
+0.3%
Scan Membership
Pullback Hunter
Latest: 2026-07-28
Prop Scan
Latest: 2026-07-28
60 appearances in last 60 days. First seen: 2026-06-12.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S2
Wk 13 · Vol —x
2026-08-06S2
Wk 12 · Vol —x
2026-08-05S2
Wk 12 · Vol —x
2026-08-04S2
Wk 12 · Vol —x
2026-08-03S2
Wk 12 · Vol —x
2026-07-31S2
Wk 12 · Vol —x
2026-07-30S2
Wk 11 · Vol —x
2026-07-29S2
Wk 11 · Vol —x
2026-07-28S2
Wk 11 · Vol —x
2026-07-27S2
Wk 11 · Vol —x
2026-07-24S2
Wk 11 · Vol —x
2026-07-23S2
Wk 10 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹115.7
200 DMA
₹85.4
52W High
₹127.9
52W Low
₹60.3
5D Low
₹109
Resistance levels (recent highs)
20d High
₹123
60d High
₹127.9
120d High
₹127.9
250d High
₹127.9
Next resistance
+9.8%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.